These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32742242)

  • 1. Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4
    Meckiff BJ; Ramírez-Suástegui C; Fajardo V; Chee SJ; Kusnadi A; Simon H; Grifoni A; Pelosi E; Weiskopf D; Sette A; Ay F; Seumois G; Ottensmeier CH; Vijayanand P
    SSRN; 2020 Jul; ():3641939. PubMed ID: 32742242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4
    Meckiff BJ; Ramírez-Suástegui C; Fajardo V; Chee SJ; Kusnadi A; Simon H; Grifoni A; Pelosi E; Weiskopf D; Sette A; Ay F; Seumois G; Ottensmeier CH; Vijayanand P
    bioRxiv; 2020 Jun; ():. PubMed ID: 32587963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4
    Meckiff BJ; Ramírez-Suástegui C; Fajardo V; Chee SJ; Kusnadi A; Simon H; Eschweiler S; Grifoni A; Pelosi E; Weiskopf D; Sette A; Ay F; Seumois G; Ottensmeier CH; Vijayanand P
    Cell; 2020 Nov; 183(5):1340-1353.e16. PubMed ID: 33096020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of SARS-CoV-2 public CD4+ αβ T cell clonotypes through reverse epitope discovery.
    Rosati E; Pogorelyy MV; Minervina AA; Scheffold A; Franke A; Bacher P; Thomas PG
    bioRxiv; 2021 Nov; ():. PubMed ID: 34845450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV.
    Lv Z; Lv S; Li Q; Xia Y; Feng Z; Zhang H; Yang H; Wu Z; Zou N; Mo Q; Gu Q; Ying S; Wang X; Qin D; Wan C
    Front Immunol; 2023; 14():1264160. PubMed ID: 38045691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 epitope-specific CD4
    Nelson RW; Chen Y; Venezia OL; Majerus RM; Shin DS; ; Carrington MN; Yu XG; Wesemann DR; Moon JJ; Luster AD
    Sci Immunol; 2022 Jul; 7(73):eabl9464. PubMed ID: 35857584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of age on the magnitude and longevity of Th1-directed CD4 T-cell responses to SARS-CoV-2.
    Nattrass RG; Krafft L; Zjablovskaja P; Schuster M; Kasmapour B; Sarisoy C; Minich J; Bach E; Streeck H
    Immunology; 2022 Jul; 166(3):327-340. PubMed ID: 35396852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection.
    Moga E; Lynton-Pons E; Domingo P
    Front Immunol; 2022; 13():904686. PubMed ID: 35833134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19.
    Kudryavtsev I; Matyushenko V; Stepanova E; Vasilyev K; Rudenko L; Isakova-Sivak I
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
    Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
    bioRxiv; 2022 Dec; ():. PubMed ID: 36482973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic Determinants of SARS-CoV-2-Specific CD4
    Gazzinelli-Guimaraes PH; Sanku G; Sette A; Weiskopf D; Schaughency P; Lack J; Nutman TB
    Front Immunol; 2022; 13():883159. PubMed ID: 35844575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.
    Vilella F; Wang W; Moreno I; Roson B; Quake SR; Simon C
    Hum Reprod; 2021 Sep; 36(10):2709-2719. PubMed ID: 34329437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments.
    Pfannes R; Pierzchalski A; Maddalon A; Simion A; Zouboulis CC; Behre G; Zenclussen AC; Westphal S; Fest S; Herberth G
    Front Immunol; 2023; 14():1087996. PubMed ID: 37187728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model.
    Prakash S; Dhanushkodi NR; Singer M; Quadiri A; Zayou L; Vahed H; Coulon PG; Ibraim IC; Tafoya C; Hitchcock L; Landucci G; Forthal DN; El Babsiri A; Tifrea DF; Figueroa CJ; Nesburn AB; Kuppermann BD; Gil D; Jones TM; Ulmer JB; BenMohamed L
    bioRxiv; 2024 Feb; ():. PubMed ID: 38405942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.
    Dykema AG; Zhang B; Woldemeskel BA; Garliss CC; Cheung LS; Choudhury D; Zhang J; Aparicio L; Bom S; Rashid R; Caushi JX; Hsiue EH; Cascino K; Thompson EA; Kwaa AK; Singh D; Thapa S; Ordonez AA; Pekosz A; D'Alessio FR; Powell JD; Yegnasubramanian S; Zhou S; Pardoll DM; Ji H; Cox AL; Blankson JN; Smith KN
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33830946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 uses CD4 to infect T helper lymphocytes.
    Brunetti NS; Davanzo GG; de Moraes D; Ferrari AJR; Souza GF; Muraro SP; Knittel TL; Boldrini VO; Monteiro LB; Virgílio-da-Silva JV; Profeta GS; Wassano NS; Nunes Santos L; Carregari VC; Dias AHS; Veras FP; Tavares LA; Forato J; Castro IMS; Silva-Costa LC; Palma AC; Mansour E; Ulaf RG; Bernardes AF; Nunes TA; Ribeiro LC; Agrela MV; Moretti ML; Buscaratti LI; Crunfli F; Ludwig RG; Gerhardt JA; Munhoz-Alves N; Marques AM; Sesti-Costa R; Amorim MR; Toledo-Teixeira DA; Parise PL; Martini MC; Bispos-Dos-Santos K; Simeoni CL; Granja F; Silvestrini VC; de Oliveira EB; Faca VM; Carvalho M; Castelucci BG; Pereira AB; Coimbra LD; Dias MMG; Rodrigues PB; Gomes ABSP; Pereira FB; Santos LMB; Bloyet LM; Stumpf S; Pontelli MC; Whelan S; Sposito AC; Carvalho RF; Vieira AS; Vinolo MAR; Damasio A; Velloso L; Figueira ACM; da Silva LLP; Cunha TM; Nakaya HI; Marques-Souza H; Marques RE; Martins-de-Souza D; Skaf MS; Proenca-Modena JL; Moraes-Vieira PMM; Mori MA; Farias AS
    Elife; 2023 Jul; 12():. PubMed ID: 37523305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
    Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
    Front Immunol; 2022; 13():769839. PubMed ID: 35422799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2-specific T cell responses and immune regulation in infected pregnant women.
    Hsieh LE; Grifoni A; Dave H; Wang J; Johnson D; Zellner J; Sidney J; Chambers C; Franco A
    J Reprod Immunol; 2022 Feb; 149():103464. PubMed ID: 34953325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Response to SARS-CoV-2 Vaccine in 2 Men.
    Gupta S; Su H; Agrawal S
    Int Arch Allergy Immunol; 2022; 183(3):350-359. PubMed ID: 34794147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.